News › Industry News, News

Debut Expands Partnership with L’Oréal to Develop and Scale Biotech Ingredients Crucial for Sustainable Beauty

July 10, 2024
L'Oréal

Debut, a biotech beauty leader and vertically integrated biotechnology company, announced that it has signed an agreement with L’Oréal to develop more than a dozen vital, bio-identical ingredients that will replace conventionally sourced ingredients currently used in L’Oréal global beauty and personal care brands across skin, hair, color cosmetics and fragrance.

As part of the agreement, Debut will create new bio-based ingredients using proprietary advanced biomanufacturing processes which combine fermentation and cell-free technology to replace conventional methods.

Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics